Alazanine

Alazanine

SCHEMBL1506901

CCN1C(=CC=Cc2sc3ccccc3[n+]2CC)Sc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 1.00
KMT2A Q03164 5/20 1.00
HTT P42858 4/20 1.00
BLM P54132 4/20 1.00
APP P05067 7/20 0.98
NPC1 O15118 5/20 0.98
RAB9A P51151 5/20 0.98
APAF1 O14727 2/20 0.98
ITGB2 P05107 1/20 0.98
ALPL P05186 1/20 0.98
ITGAM P11215 1/20 0.98
GFER P55789 1/20 0.98
L3MBTL1 Q9Y468 1/20 0.98
ALDH1A1 P00352 2/20 0.90
POLB P06746 2/20 0.90
MAPT P10636 2/20 0.90
THRB P10828 2/20 0.90
PKM P14618 2/20 0.90
RECQL P46063 2/20 0.90
SMN1; SMN2 Q16637 2/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alazanine SCHEMBL12364489 1.00 MEN1 (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL1506900 1.00 MEN1 (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL10020546 1.00 MEN1 (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL30133356 1.00 MEN1 (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL142862 0.99 APP (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL11690918 0.99 MEN1 (0.98) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL29887077 0.99 APP (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL31179678 0.99 MEN1 (0.98) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL29556313 0.99 APP (1.00) MEN1KMT2AHTTBLMAPP
Alazanine SCHEMBL5453750 0.99 APP (1.00) MEN1KMT2AHTTBLMAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8021839-B2 Quantitative analysis; optical properties; kits INVESTIGEN, INC. (US) 2011-09-20 US claimed
EP-2010677-A2 METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDES Investigen, Inc. (US) 2009-01-07 EP claimed
US-20070231821-A1 Methods and compositions for detecting polynucleotides INVESTIGEN, INC. 2007-10-04 US claimed
WO-2007100711-A2 METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDES INVESTIGEN, INC. (US) 2007-09-07 WO claimed
EP-1787679-A1 Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-23 EP claimed
US-20240226198-A1 NOVEL LACTIC ACID BACTERIA AND USE THEREOF PBLBIOLAB (KR) 2024-07-11 US disclosed
WO-2024091146-A1 UNLEADED AVIATION GASOLINE FUEL COMPOSITION Публичное акционерное общество "Газпром нефть" 2024-05-02 WO disclosed
US-20230322987-A1 COLORED RESIN COMPOSITION, OPTICAL FILTER, AND METHOD OF MANUFACTURING OPTICAL FILTER TOPPAN INC. (JP) 2023-10-12 US disclosed
US-20230151229-A1 INFRARED CUT FILTER, SOLID-STATE IMAGE SENSOR FILTER, SOLID-STATE IMAGE SENSOR, AND METHOD OF PRODUCING SOLID-STATE IMAGE SENSOR TOPPAN INC. (JP) 2023-05-18 US disclosed
WO-2022065848-A1 NOVEL LACTIC ACID BACTERIA AND USE THEREOF 피비엘바이오랩 주식회사 2022-03-31 WO disclosed
US-9658197-B2 Standard material for a particle analyzer SYSMEX CORPORATION (JP) 2017-05-23 US disclosed
US-20160334705-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR KODAK REALTY INC. 2016-11-17 US disclosed
WO-2005021661-A1 CYANOBORATE, FLUOROALKYL PHOSPHATE, FLUOROALKYL BORATE OR IMIDE DYES MERCK PATENT GMBH (DE) 2005-03-10 WO disclosed
WO-2005017181-A2 SYSTEM FOR DETECTING POLYNUCLEOTIDES INVESTIGEN, INC. (US) 2005-02-24 WO disclosed
US-20050040390-A1 Doped organic semiconductor material and method for production thereof NOVALED AG (DE) 2005-02-24 US disclosed
EP-1476881-A2 DOPED ORGANIC SEMICONDUCTOR MATERIAL AND METHOD FOR PRODUCTION THEREOF Novaled GmbH (DE) 2004-11-17 EP disclosed
WO-2003070822-A2 DOPED ORGANIC SEMICONDUCTOR MATERIAL AND METHOD FOR PRODUCTION THEREOF NOVALED GMBH (DE) 2003-08-28 WO disclosed
US-6335531-B1 Modification of resist and/or resist processing with fluorescence detection MICRON TECHNOLOGY, INC. 2002-01-01 US disclosed
US-5314725-A Photo-plating process KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 1994-05-24 US disclosed
US-4343782-A Cytological assay procedure SHAPIRO HOWARD M 1982-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070231821-A1 Methods and compositions for detecting polynucleotides POLN, POLRMT, POLH MEN1 3712/4885KMT2A 4752/4885HTT 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.